Dubravka Erzen-Jurisic

Rijeka, Croatia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

From obesity to healthy longevity: a consensus-based clinical framework for diagnosis, staging, and treatment.

From obesity to healthy longevity: a consensus-based clinical framework for diagnosis, staging, and treatment.

Journal: Frontiers in aging

Published: March 19, 2026

Adverse Pregnancy Outcomes in Women with Gestational Diabetes Using Different Diagnostic Criteria: A Study from the Northern Adriatic Region of Croatia.

Adverse Pregnancy Outcomes in Women with Gestational Diabetes Using Different Diagnostic Criteria: A Study from the Northern Adriatic Region of Croatia.

Journal: Medicina (Kaunas, Lithuania)

Published: September 25, 2025

Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity.

Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity.

Journal: International journal of molecular sciences

Published: December 30, 2023

The Importance of Acromegaloid Physical Features for Clinical Practice.

The Importance of Acromegaloid Physical Features for Clinical Practice.

Journal: Case reports in endocrinology

Published: June 17, 2023

Glycemic Variability in Type 1 Diabetes Mellitus Pregnancies-Novel Parameters in Predicting Large-for-Gestational-Age Neonates: A Prospective Cohort Study.

Glycemic Variability in Type 1 Diabetes Mellitus Pregnancies-Novel Parameters in Predicting Large-for-Gestational-Age Neonates: A Prospective Cohort Study.

Journal: Biomedicines

Published: July 31, 2022

Patient-reported outcomes in adults with type 1 diabetes in global real-world clinical practice: The SAGE study.

Patient-reported outcomes in adults with type 1 diabetes in global real-world clinical practice: The SAGE study.

Journal: Diabetes, obesity & metabolism

Published: December 11, 2020

Pregnancy in Patients with Type One Diabetes Mellitus Treated with Continuous Subcutaneous Insulin Infusion-Preconception Basal Insulin Dose as a Potential Risk Factor for Fetal Overgrowth?

Pregnancy in Patients with Type One Diabetes Mellitus Treated with Continuous Subcutaneous Insulin Infusion-Preconception Basal Insulin Dose as a Potential Risk Factor for Fetal Overgrowth?

Journal: International journal of environmental research and public health

Published: July 18, 2020

The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM.

The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM.

Journal: Diabetes/metabolism research and reviews

Published: April 07, 2020

Severe Lipoatrophy in a Patient With Type 2 Diabetes in Response to Human Insulin Analogs Glargine and Degludec: Possible Involvement of CD4 T Cell-Mediated Tissue Remodeling.

Severe Lipoatrophy in a Patient With Type 2 Diabetes in Response to Human Insulin Analogs Glargine and Degludec: Possible Involvement of CD4 T Cell-Mediated Tissue Remodeling.

Journal: Diabetes care

Published: September 25, 2019

Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose-lowering therapy?

Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose-lowering therapy?

Journal: Diabetes, obesity & metabolism

Published: August 02, 2019

CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzle.

CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzle.

Journal: Diabetes research and clinical practice

Published: April 01, 2019

Commentary: Short Body Height and Pre-pregnancy Overweight for Increased Risk of Gestational Diabetes Mellitus: A Population-Based Cohort Study.

Commentary: Short Body Height and Pre-pregnancy Overweight for Increased Risk of Gestational Diabetes Mellitus: A Population-Based Cohort Study.

Journal: Frontiers in endocrinology

Published: July 08, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026